SFMBT2 and prostate carcinoma: In case of LNCaP, SFMBT2 interacts with YY1 and represses MMP2, MMP3, and MMP9 and inhibits invasion and migration of prostate cancer cells, and illustrating both pro and anti-role of YY1 in prostate cancer growth.